Jonathan Symonds [via HSBC]

GSK to tap Jonathan Symonds as chair­man, lever­ag­ing Big Phar­ma ex­pe­ri­ence for con­sumer biz deal

Six months in­to its search for a new board chair­man, Glax­o­SmithK­line has ap­par­ent­ly found the per­fect can­di­date in a sea­soned ex­ec­u­tive groomed at As­traZeneca and No­var­tis. Jonathan Symonds is in the fi­nal stages of be­ing ap­point­ed, Bloomberg re­ports.

In Jan­u­ary Sir Philip Hamp­ton an­nounced his in­ten­tion to step down and make way for a new leader to over­see the con­sumer health joint ven­ture GSK is set­ting up with Pfiz­er. The deal — an­nounced a month pri­or — would spin out the unit for­mer­ly head­ed by GSK CEO Em­ma Walm­s­ley and merge it with the equiv­a­lent di­vi­sion at Pfiz­er to cre­ate a new en­ti­ty to be list­ed sep­a­rate­ly.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.